Presenting at 2024 Wells Fargo Healthcare Conference, McKesson said it expects Q2 adjusted EPS to be between $6.70-$7 per share. Consensus at $7.39. The company also affirmed FY25 adjusted EPS guidance in the range of $31.75-$32.55, with consensus at $32.21. Shares of McKesson have dropped over 9% to $519.22 in afternoon trading.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- McKesson Projects Strong Earnings, Cautions on Forward-Looking Statements
- McKesson price target lowered to $665 from $670 at Leerink
- McKesson selling Rexall and Well.ca businesses to Birch Hill Equity Partners
- Boeing’s Starliner to return without astronauts: Morning Buzz
- McKesson Expands Influence with Core Ventures Acquisition